Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raj Bhayadia

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Blood|September 27, 2021
The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesisOriol Alejo-Valle, Karoline Weigert, Raj Bhayadia, et al.
Nature Communications|September 30, 2024
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cellsTobias Bexte, Nawid Albinger, Ahmad Al Ajami, et al.
Blood Advances|April 7, 2026
DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid LeukemiaLonneke Verboon, Sonali P Barwe, Meredith Tavenner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2018
Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid LeukemiaRaj Bhayadia, Kathrin Krowiorz, Nadine Haetscher, et al.
Leukemia|November 7, 2023
PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemiaIslam Alshamleh, Nina Kurrle, Philipp Makowka, et al.
Blood|December 9, 2022
RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemiaSofia Gialesaki, Daniela Bräuer-Hartmann, Hasan Issa, et al.
Kidney International|May 20, 2018
Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysisBetti Schaefer, Maria Bartosova, Stephan Macher-Goeppinger, et al.
Cancer Cell|September 19, 2019
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down SyndromeMaurice Labuhn, Kelly Perkins, Sören Matzk, et al.
Cancer Cell|July 16, 2019
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down SyndromeMaurice Labuhn, Kelly Perkins, Sören Matzk, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Blood|September 27, 2021
The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesisOriol Alejo-Valle, Karoline Weigert, Raj Bhayadia, et al.
Nature Communications|September 30, 2024
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cellsTobias Bexte, Nawid Albinger, Ahmad Al Ajami, et al.
Blood Advances|April 7, 2026
DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid LeukemiaLonneke Verboon, Sonali P Barwe, Meredith Tavenner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2018
Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid LeukemiaRaj Bhayadia, Kathrin Krowiorz, Nadine Haetscher, et al.
Leukemia|November 7, 2023
PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemiaIslam Alshamleh, Nina Kurrle, Philipp Makowka, et al.
Blood|December 9, 2022
RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemiaSofia Gialesaki, Daniela Bräuer-Hartmann, Hasan Issa, et al.
Kidney International|May 20, 2018
Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysisBetti Schaefer, Maria Bartosova, Stephan Macher-Goeppinger, et al.
Cancer Cell|September 19, 2019
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down SyndromeMaurice Labuhn, Kelly Perkins, Sören Matzk, et al.
Cancer Cell|July 16, 2019
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down SyndromeMaurice Labuhn, Kelly Perkins, Sören Matzk, et al.
Pageof 2